Frontlight ResearchEarly access
Amyloidosis trials in Portugal
6 of 14 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Where
- Lisbon, Porto
- People
- 1,500 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT04561518 - No phaseTaking peoplePatisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
- Where
- Lisbon
- People
- 10 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT05040373 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - No phaseTaking peopleOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- Lisbon, Porto
- People
- 52,121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934 - No phaseTaking peopleRetinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
- Where
- Guimarães, Lisbon
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07690436 - No phaseTaking peopleInternational Cardiac Amyloidosis Registry
- Where
- Lisbon
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT06894290